- Home
- GROW vs LVTX Comparison
GROW vs LVTX Comparison
Compare GROW & LVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GROW
- LVTX
- Stock Information
- Founded
- GROW 1968
- LVTX 2016
- Country
- GROW United States
- LVTX Netherlands
- Employees
- GROW N/A
- LVTX N/A
- Industry
- GROW Investment Managers
- LVTX Biotechnology: Pharmaceutical Preparations
- Sector
- GROW Finance
- LVTX Health Care
- Exchange
- GROW Nasdaq
- LVTX Nasdaq
- Market Cap
- GROW 27.4M
- LVTX 30.0M
- IPO Year
- GROW N/A
- LVTX 2021
- Fundamental
- Price
- GROW $2.16
- LVTX $1.26
- Analyst Decision
- GROW
- LVTX Hold
- Analyst Count
- GROW 0
- LVTX 3
- Target Price
- GROW N/A
- LVTX $3.17
- AVG Volume (30 Days)
- GROW 18.6K
- LVTX 46.3K
- Earning Date
- GROW 05-08-2025
- LVTX 05-20-2025
- Dividend Yield
- GROW 4.19%
- LVTX N/A
- EPS Growth
- GROW N/A
- LVTX N/A
- EPS
- GROW 0.01
- LVTX N/A
- Revenue
- GROW $8,932,000.00
- LVTX $11,982,000.00
- Revenue This Year
- GROW N/A
- LVTX N/A
- Revenue Next Year
- GROW N/A
- LVTX N/A
- P/E Ratio
- GROW $203.47
- LVTX N/A
- Revenue Growth
- GROW N/A
- LVTX 77.01
- 52 Week Low
- GROW $2.02
- LVTX $0.85
- 52 Week High
- GROW $2.73
- LVTX $3.20
- Technical
- Relative Strength Index (RSI)
- GROW 49.46
- LVTX 50.12
- Support Level
- GROW $2.09
- LVTX $1.22
- Resistance Level
- GROW $2.23
- LVTX $1.30
- Average True Range (ATR)
- GROW 0.05
- LVTX 0.07
- MACD
- GROW 0.01
- LVTX -0.00
- Stochastic Oscillator
- GROW 50.00
- LVTX 36.96
About GROW U.S. Global Investors Inc.
US Global Investors Inc is a registered investment advisory firm. The company manages the following business segments: Investment management services; through which the company offers, to U.S. Global Investors Funds (USGIF or the Funds) and exchange-traded fund (ETF) clients, a range of investment management products and services to meet the needs of individual and institutional investors; and Corporate Investments, through which the company invests for its own account in an effort to add growth and value to its cash position. It derives all its revenue from Investment management services.
About LVTX LAVA Therapeutics N.V.
LAVA Therapeutics NV isa clinical stage immuno-oncology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigen for the treatment of cancer. Company's pipeline include's products such as LAVA-1266, LAVA-1427, LAVA-1433, LAVA-1207, PF08046052, JNJ89853413.